Bicycle Therapeutics plc (BCYC)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-07-30) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-04-30) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-17) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-10-30) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-08) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-01) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-25) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-31) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-06) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-02) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-20) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Shareholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Shareholders' Equity (P) | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Benefit Plans | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Fair Value of Financial Assets and Liabilities | ||
| Geographic Information | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Long-term Debt | ||
| Nature of The Business and Basis of Presentation | ||
| Net Loss Per Share | ||
| Ordinary Shares | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | ||
| Related Party Transactions | ||
| Segments and Geographic Information | ||
| Share-based Compensation | ||
| Significant Agreements | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||